Marshall Wace’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Buy
+68,047
New +$3.66M ﹤0.01% 1439
2025
Q4
Sell
-54,416
Closed -$1.67M 2927
2025
Q3
$1.67M Buy
+54,416
New +$1.25M ﹤0.01% 1708
2025
Q2
Sell
-92,870
Closed -$1.73M 2674
2025
Q1
$1.73M Buy
+92,870
New +$1.55M ﹤0.01% 1533
2024
Q4
Sell
-8,978
Closed -$301K 2556
2024
Q3
$301K Buy
+8,978
New +$307K ﹤0.01% 2143
2024
Q1
Sell
-33,357
Closed -$715K 2413
2023
Q4
$715K Sell
33,357
-1,520
-4% -$26.2K ﹤0.01% 1592
2023
Q3
$626K Buy
34,877
+21,576
+162% +$412K ﹤0.01% 1650
2023
Q2
$271K Sell
13,301
-11,096
-45% -$225K ﹤0.01% 2170
2023
Q1
$531K Buy
+24,397
New +$593K ﹤0.01% 2076
2018
Q4
Sell
-108,870
Closed -$10.9M 1570
2018
Q3
$10.9M Buy
+108,870
New +$9.03M 0.09% 287
2018
Q2
Sell
-6,969
Closed -$725K 696
2018
Q1
$725K Buy
+6,969
New +$785K 0.03% 294

Other funds holding ANAB